Mirae Asset Global Investments Co., Ltd. Novartis Ag Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 107,681 shares of NVS stock, worth $12.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
107,681
Previous 82,727
30.16%
Holding current value
$12.5 Million
Previous $8 Million
43.25%
% of portfolio
0.06%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.42 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$860 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$859 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$689 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...